| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735386 | Hepatobiliary & Pancreatic Diseases International | 2017 | 8 Pages |
Abstract
PC-P159T (ntC2288A), BCP-N118T (ntA1726C), BCP-L134L (ntA1775C/G/T), PC-G182C (ntG2357T) and PC-S64A/T (ntT2003G/A) were novel identified mutations that impacted IFN therapeutic efficacy. These novel mutations could serve as important predictors before conventional IFN treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Da-Xian Wu, Xiao-Yu Fu, Guo-Zhong Gong, Ke-Wei Sun, Huan-Yu Gong, Ling Wang, Juan Wu, De-Ming Tan,